Drug Farm reports DF-003 reduces kidney fibrosis in preclinical ALPK1 study
Drug Farm reports DF-003 reduced kidney fibrosis in preclinical research, revealing a potential ALPK1 treatment pathway. Human efficacy remains unproven.
Pharma & Biotech
Pharma & Biotech
Sensorion’s SENS-601 strategy signals a sharper bet on larger genetic hearing loss markets
Find out how Sensorion’s SENS-601 regulatory push could reshape GJB2 hearing loss gene therapy and clinical strategy.